Article in Journal of clinical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Simon KurmannSection of Immunology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Marco A CoelhoDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0002-5716-0561
Márcia David-PalmaDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0002-5515-7625
Leyna DíazVeterinary Mycology Group, Department of Animal Health and Anatomy, Veterinary School, Universitat Autònoma de Barcelona, Bellaterra, Spain.ORCID 0000-0003-3195-8732
Gemma CastelláVeterinary Mycology Group, Department of Animal Health and Anatomy, Veterinary School, Universitat Autònoma de Barcelona, Bellaterra, Spain.ORCID 0000-0002-8404-0688
F Javier CabañesVeterinary Mycology Group, Department of Animal Health and Anatomy, Veterinary School, Universitat Autònoma de Barcelona, Bellaterra, Spain.ORCID 0000-0002-2244-5778
Joseph HeitmanDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA.ORCID 0000-0001-6369-5995
Salomé LeibundGut-Landmann *Section of Immunology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-5724-4837
Francis Muchaamba *Institute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.ORCID 0000-0003-2266-3318
Funding
Malassezia and Candida auris: skin microbiome dysbiosis and de-regulation of cutaneous homeostasisR21AI168672 · NIAID · DUKE UNIVERSITY · PI HEITMAN, JOSEPH, LEIBUNDGUT-LANDMANN, SALOME · 2023 to 2024
$400k
NIAID NIH HHS R21 AI168672NIH HHS R21 AI168672-02Swiss National Science Foundation 320030-227692University of Zurich
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Fourier transform infrared spectroscopy enables rapid strain typing in · full record | Socratic